European Urology published a clinical update in Research Highlights on 03 Feb 2026. The item focuses on Re: Disitamab Vedotin plus Toripalimab in HER2-expressing Advanced Urothelial Cancer. Review the original article for the full source wording and details.
Sheng X, Zeng G, Zhang C, et al.